169 related articles for article (PubMed ID: 22153663)
1. Ligand based design of novel histamine H₄ receptor antagonists; fragment optimization and analysis of binding kinetics.
Smits RA; Lim HD; van der Meer T; Kuhne S; Bessembinder K; Zuiderveld OP; Wijtmans M; de Esch IJ; Leurs R
Bioorg Med Chem Lett; 2012 Jan; 22(1):461-7. PubMed ID: 22153663
[TBL] [Abstract][Full Text] [Related]
2. Discovery of quinazolines as histamine H4 receptor inverse agonists using a scaffold hopping approach.
Smits RA; de Esch IJ; Zuiderveld OP; Broeker J; Sansuk K; Guaita E; Coruzzi G; Adami M; Haaksma E; Leurs R
J Med Chem; 2008 Dec; 51(24):7855-65. PubMed ID: 19053770
[TBL] [Abstract][Full Text] [Related]
3. Molecular determinants of ligand binding modes in the histamine H(4) receptor: linking ligand-based three-dimensional quantitative structure-activity relationship (3D-QSAR) models to in silico guided receptor mutagenesis studies.
Istyastono EP; Nijmeijer S; Lim HD; van de Stolpe A; Roumen L; Kooistra AJ; Vischer HF; de Esch IJ; Leurs R; de Graaf C
J Med Chem; 2011 Dec; 54(23):8136-47. PubMed ID: 22003888
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel human histamine H4 receptor ligands by large-scale structure-based virtual screening.
Kiss R; Kiss B; Könczöl A; Szalai F; Jelinek I; László V; Noszál B; Falus A; Keseru GM
J Med Chem; 2008 Jun; 51(11):3145-53. PubMed ID: 18459760
[TBL] [Abstract][Full Text] [Related]
5. cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.
Liu H; Altenbach RJ; Carr TL; Chandran P; Hsieh GC; Lewis LG; Manelli AM; Milicic I; Marsh KC; Miller TR; Strakhova MI; Vortherms TA; Wakefield BD; Wetter JM; Witte DG; Honore P; Esbenshade TA; Brioni JD; Cowart MD
J Med Chem; 2008 Nov; 51(22):7094-8. PubMed ID: 18983139
[TBL] [Abstract][Full Text] [Related]
6. Preparation and biological evaluation of indole, benzimidazole, and thienopyrrole piperazine carboxamides: potent human histamine h(4) antagonists.
Venable JD; Cai H; Chai W; Dvorak CA; Grice CA; Jablonowski JA; Shah CR; Kwok AK; Ly KS; Pio B; Wei J; Desai PJ; Jiang W; Nguyen S; Ling P; Wilson SJ; Dunford PJ; Thurmond RL; Lovenberg TW; Karlsson L; Carruthers NI; Edwards JP
J Med Chem; 2005 Dec; 48(26):8289-98. PubMed ID: 16366610
[TBL] [Abstract][Full Text] [Related]
7. Development of a selective and potent radioactive ligand for histamine H(3) receptors: A compound potentially useful for receptor occupancy studies.
Mitobe Y; Ito S; Mizutani T; Nagase T; Sato N; Tokita S
Bioorg Med Chem Lett; 2009 Aug; 19(15):4075-8. PubMed ID: 19553110
[TBL] [Abstract][Full Text] [Related]
8. INCB38579, a novel and potent histamine H₄ receptor small molecule antagonist with anti-inflammatory pain and anti-pruritic functions.
Shin N; Covington M; Bian D; Zhuo J; Bowman K; Li Y; Soloviev M; Qian DQ; Feldman P; Leffet L; He X; He Wang K; Krug K; Bell D; Czerniak P; Hu Z; Zhao H; Zhang J; Yeleswaram S; Yao W; Newton R; Scherle P
Eur J Pharmacol; 2012 Jan; 675(1-3):47-56. PubMed ID: 22155710
[TBL] [Abstract][Full Text] [Related]
9. A new class of histamine H3 receptor antagonists derived from ligand based design.
Roche O; Rodríguez Sarmiento RM
Bioorg Med Chem Lett; 2007 Jul; 17(13):3670-5. PubMed ID: 17498953
[TBL] [Abstract][Full Text] [Related]
10. Identification and hit-to-lead exploration of a novel series of histamine H4 receptor inverse agonists.
Cramp S; Dyke HJ; Higgs C; Clark DE; Gill M; Savy P; Jennings N; Price S; Lockey PM; Norman D; Porres S; Wilson F; Jones A; Ramsden N; Mangano R; Leggate D; Andersson M; Hale R
Bioorg Med Chem Lett; 2010 Apr; 20(8):2516-9. PubMed ID: 20299215
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and SAR of 1,2,3,4-tetrahydroisoquinolin-1-ones as novel G-protein-coupled receptor 40 (GPR40) antagonists.
Humphries PS; Benbow JW; Bonin PD; Boyer D; Doran SD; Frisbie RK; Piotrowski DW; Balan G; Bechle BM; Conn EL; Dirico KJ; Oliver RM; Soeller WC; Southers JA; Yang X
Bioorg Med Chem Lett; 2009 May; 19(9):2400-3. PubMed ID: 19346127
[TBL] [Abstract][Full Text] [Related]
12. Lead identification and optimization of diaminopyrimidines as histamine H4 receptor ligands.
Sander K; Kottke T; Proschak E; Tanrikulu Y; Schneider EH; Seifert R; Schneider G; Stark H
Inflamm Res; 2010 Mar; 59 Suppl 2():S249-51. PubMed ID: 20012148
[TBL] [Abstract][Full Text] [Related]
13. Novel H3 receptor antagonists with improved pharmacokinetic profiles.
Santora VJ; Covel JA; Hayashi R; Hofilena BJ; Ibarra JB; Pulley MD; Weinhouse MI; Semple G; Ren A; Pereira G; Edwards JE; Suarez M; Frazer J; Thomsen W; Hauser E; Lorea J; Grottick AJ
Bioorg Med Chem Lett; 2008 Jul; 18(14):4133-6. PubMed ID: 18554904
[TBL] [Abstract][Full Text] [Related]
14. Paradoxical stimulatory effects of the "standard" histamine H4-receptor antagonist JNJ7777120: the H4 receptor joins the club of 7 transmembrane domain receptors exhibiting functional selectivity.
Seifert R; Schneider EH; Dove S; Brunskole I; Neumann D; Strasser A; Buschauer A
Mol Pharmacol; 2011 Apr; 79(4):631-8. PubMed ID: 21266488
[TBL] [Abstract][Full Text] [Related]
15. Discovery and SAR of 6-alkyl-2,4-diaminopyrimidines as histamine H₄ receptor antagonists.
Savall BM; Chavez F; Tays K; Dunford PJ; Cowden JM; Hack MD; Wolin RL; Thurmond RL; Edwards JP
J Med Chem; 2014 Mar; 57(6):2429-39. PubMed ID: 24495018
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity studies on a series of a 2-aminopyrimidine-containing histamine H4 receptor ligands.
Altenbach RJ; Adair RM; Bettencourt BM; Black LA; Fix-Stenzel SR; Gopalakrishnan SM; Hsieh GC; Liu H; Marsh KC; McPherson MJ; Milicic I; Miller TR; Vortherms TA; Warrior U; Wetter JM; Wishart N; Witte DG; Honore P; Esbenshade TA; Hancock AA; Brioni JD; Cowart MD
J Med Chem; 2008 Oct; 51(20):6571-80. PubMed ID: 18811133
[TBL] [Abstract][Full Text] [Related]
17. Homology model adjustment and ligand screening with a pseudoreceptor of the human histamine H4 receptor.
Tanrikulu Y; Proschak E; Werner T; Geppert T; Todoroff N; Klenner A; Kottke T; Sander K; Schneider E; Seifert R; Stark H; Clark T; Schneider G
ChemMedChem; 2009 May; 4(5):820-7. PubMed ID: 19343764
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity relationships of indole and benzimidazole piperazines as histamine H(4) receptor antagonists.
Terzioglu N; van Rijn RM; Bakker RA; De Esch IJ; Leurs R
Bioorg Med Chem Lett; 2004 Nov; 14(21):5251-6. PubMed ID: 15454206
[TBL] [Abstract][Full Text] [Related]
19. Interactions of histamine H1-receptor agonists and antagonists with the human histamine H4-receptor.
Deml KF; Beermann S; Neumann D; Strasser A; Seifert R
Mol Pharmacol; 2009 Nov; 76(5):1019-30. PubMed ID: 19720730
[TBL] [Abstract][Full Text] [Related]
20. Validation of a histamine H3 receptor model through structure-activity relationships for classical H3 antagonists.
Lorenzi S; Mor M; Bordi F; Rivara S; Rivara M; Morini G; Bertoni S; Ballabeni V; Barocelli E; Plazzi PV
Bioorg Med Chem; 2005 Oct; 13(19):5647-57. PubMed ID: 16085419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
